日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED)

铂类药物联合依托泊苷和度伐利尤单抗治疗伴有未治疗脑转移的广泛期小细胞肺癌:一项多中心、单臂 II 期试验(LOGiK2001、SPEED)

Shiraishi, Y; Shimose, T; Tsuchiya-Kawano, Y; Ishii, H; Mizuno, K; Toi, Y; Daga, H; Ito, K; Iyama, S; Taniguchi, H; Morinaga, R; Harada, T; Inoue, H; Misumi, Y; Naoki, K; Tobino, K; Izumi, M; Omori, S; Tsumura, S; Yamanaka, Y; Sakata, Y; Miura, S; Mizutani, H; Oki, M; Iwama, E; Otsubo, K; Okamoto, I

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.

LKB1 肿瘤抑制基因的突变在白种人肺癌患者的肿瘤中经常被检测到,但在亚洲肺癌患者的肿瘤中则很少被检测到

Koivunen J P, Kim J, Lee J, Rogers A M, Park J O, Zhao X, Naoki K, Okamoto I, Nakagawa K, Yeap B Y, Meyerson M, Wong K-K, Richards W G, Sugarbaker D J, Johnson B E, Jänne P A